| Financial Year |
March 31 2023 |
| Monetary Funds |
436,655,614.81 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
7,228,826.21 |
| Advances to Suppliers |
8,019,644.38 |
| Other Receivables |
21,293,928.76 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
319,887,229.97 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
20,203,539.70 |
| Total Current Assets |
813,288,783.83 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
44,708,515.89 |
| Investment Properties |
-- |
| Fixed Assetes |
2,938,694,470.85 |
| Under-construction Projects |
673,794,151.39 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
174,721,090.79 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
32,516,110.71 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
61,119.00 |
| Deferred Income Tax Assets |
491,718.90 |
| Other Non-Current Assets |
2,296,728.64 |
| Sub-Total of Non-Current Assets |
4,106,262,300.77 |
| Total Assets |
4,919,551,084.60 |
| Short-Term Loans |
658,970,295.15 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
345,223,631.63 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
16,825,855.43 |
| Taxes Payable |
7,944,247.77 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
6,899,604.11 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
31,460,568.16 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
1,067,560,331.75 |
| Long-term Loans |
728,447,817.24 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
26,622,357.09 |
| Special Payable |
-- |
| Estimatied Liabilities |
11,154,582.69 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
936,983,343.29 |
| Total Liabilities |
2,004,543,675.04 |
| Paid-In Capital(Or Share Stock) |
212,805,600.00 |
| Capital Surplus |
1,866,531,997.00 |
| Surplus Reserve |
89,291,109.79 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
745,419,329.56 |
| Minority Stockholder's Interest |
959,373.21 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,914,048,036.35 |
| Owner's Equity（Stockholder's Equity） |
2,915,007,409.56 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,919,551,084.60 |
